These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26858277)

  • 1. Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey.
    Hemkens LG; Contopoulos-Ioannidis DG; Ioannidis JP
    BMJ; 2016 Feb; 352():i493. PubMed ID: 26858277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
    Anglemyer A; Horvath HT; Bero L
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study.
    Toews I; Anglemyer A; Nyirenda JL; Alsaid D; Balduzzi S; Grummich K; Schwingshackl L; Bero L
    Cochrane Database Syst Rev; 2024 Jan; 1(1):MR000034. PubMed ID: 38174786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study.
    Mc Cord KA; Ewald H; Agarwal A; Glinz D; Aghlmandi S; Ioannidis JPA; Hemkens LG
    BMJ; 2021 Mar; 372():n450. PubMed ID: 33658187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey.
    Hemkens LG; Contopoulos-Ioannidis DG; Ioannidis JP
    CMAJ Open; 2016; 4(2):E132-40. PubMed ID: 27398355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrandomized studies using causal-modeling may give different answers than RCTs: a meta-epidemiological study.
    Ewald H; Ioannidis JPA; Ladanie A; Mc Cord K; Bucher HC; Hemkens LG
    J Clin Epidemiol; 2020 Feb; 118():29-41. PubMed ID: 31704350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bias in the Evaluation of Bias Comparing Randomized Trials with Nonexperimental Studies.
    Franklin JM; Dejene S; Huybrechts KF; Wang SV; Kulldorff M; Rothman KJ
    Epidemiol Methods; 2017 Apr; 6(1):. PubMed ID: 29204330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study.
    Moneer O; Daly G; Skydel JJ; Nyhan K; Lurie P; Ross JS; Wallach JD
    BMJ; 2022 May; 377():e069400. PubMed ID: 35537738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of All-Cause Mortality Following VTE Treatment Between Propensity Score-Adjusted Observational Studies and Matched Randomized Controlled Trials: Meta-Epidemiologic Study.
    Coscia C; Jaureguizar A; Quezada CA; Muriel A; Monreal M; Villén T; Barbero E; Chiluiza D; Yusen RD; Jimenez D
    Chest; 2019 Apr; 155(4):689-698. PubMed ID: 30961834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
    Savović J; Jones H; Altman D; Harris R; Jűni P; Pildal J; Als-Nielsen B; Balk E; Gluud C; Gluud L; Ioannidis J; Schulz K; Beynon R; Welton N; Wood L; Moher D; Deeks J; Sterne J
    Health Technol Assess; 2012 Sep; 16(35):1-82. PubMed ID: 22989478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can We Trust Observational Studies Using Propensity Scores in the Critical Care Literature? A Systematic Comparison With Randomized Clinical Trials.
    Kitsios GD; Dahabreh IJ; Callahan S; Paulus JK; Campagna AC; Dargin JM
    Crit Care Med; 2015 Sep; 43(9):1870-9. PubMed ID: 26086943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Lack of Blinding and Mortality Results in Critical Care Randomized Controlled Trials: A Meta-Epidemiological Study.
    Martin GL; Trioux T; Gaudry S; Tubach F; Hajage D; Dechartres A
    Crit Care Med; 2021 Oct; 49(10):1800-1811. PubMed ID: 33927122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids as adjunctive therapy in the treatment of influenza.
    Lansbury L; Rodrigo C; Leonardi-Bee J; Nguyen-Van-Tam J; Lim WS
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD010406. PubMed ID: 30798570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small class sizes for improving student achievement in primary and secondary schools: a systematic review.
    Filges T; Sonne-Schmidt CS; Nielsen BCV
    Campbell Syst Rev; 2018; 14(1):1-107. PubMed ID: 37131395
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.